Home › NDC Lookup › Drug shortages › Allopurinol Tablet

This page is curated, coded, and maintained by

Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy

Allopurinol Tablet shortage

Not a nationwide shortage — Teva Pharmaceuticals has told the FDA it is discontinuing its allopurinol tablets. The FDA lists this under “To be discontinued” as of Oct 6, 2026: a company stopping its own product. 28 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.

To Be Discontinued ⚠ Supply risk: Low Oncology, Renal, Rheumatology 4 products 230 days First posted Feb 19, 2026 Updated Feb 19, 2026
Here’s the bottom line

Teva is permanently stopping its allopurinol tablets. Both the 100 mg and 300 mg strengths are still listed by other makers, including Mylan, Par, Major Pharmaceuticals, and Rising Pharma.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this medicine? See the ‘What to do’ note from Dr. Brian Staiger, PharmD →
4
Affected NDCs
0/1
Reporting makers with supply
2/2
Affected strengths still listed
28
Other companies listing it
230
Days on the list
3,933
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 6, 2026 · yesterday

Is allopurinol still in shortage? — status as of Oct 6, 2026

Still listed as “To be discontinued” as of Oct 6, 2026. Teva Pharmaceuticals is stopping its own version only; 28 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.

⚠ Supply risk: Low 0 of 5 risk factors
  1. Every strength is still listed by a company — 2 of 2 strengths (2 only by other companies)
  2. More than one company still lists it — 0 of 1 reporting company with supply + 28 other companies
  3. Most affected NDCs still available — supply listed
  4. Not a long-running shortage — 229 days (a discontinuation notice, not an outage)
  5. Listed by several companies — 29 companies (1 reporting + 28 other)

A rule-based estimate of national supply risk, counting both the companies reporting the shortage and the companies listing the same medicine without a report — never your local pharmacy’s stock. How the rating works.

The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are in the green card, and the Supply-Risk rating counts them too.

Availability of affected NDCs
From the FDA shortage report
4 NDCs
To be discontinued 4
Affected strengths still listed by a company
A company on the shortage report with supply, or another company selling that strength
2/2 strengths
Still made by a company 2
Reporting companies with supply
Among the 1 company that reported this shortage — plus 28 other companies listing it, below
0/1 reporting
Reporting no supply 1
✓ Other companies listing the same medicine — not reporting a shortage
Allopurinol Tablet listings in the current FDA NDC Directory from companies that have not filed a shortage report — these are not counted in the charts above. Some are repackagers of another company’s product. Stock can still vary by pharmacy.
Mylan Pharmaceuticals Inc. Par Health USA, LLC Major Pharmaceuticals Rising Pharma Holdings, Inc. NorthStar RxLLC Accord Healthcare Inc. Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. Unichem Pharmaceuticals (USA), Inc. Camber Pharmaceuticals, Inc. PD-Rx Pharmaceuticals, Inc. Aphena Pharma Solutions - Tennessee, LLC Safecor Health, LLC A-S Medication Solutions Sun Pharmaceutical Industries, Inc. Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited American Health Packaging St. Mary's Medical Park Pharmacy Chartwell RX, LLC Proficient Rx LP Bryant Ranch Prepack NuCare Pharmaceuticals, Inc. Leading Pharma, LLC REMEDYREPACK INC. Zydus Pharmaceuticals (USA) Inc. Florida Pharmaceutical Products, LLC Direct_Rx XLCare Pharmaceuticals Inc.
See all other options & details →
Shortage timeline
  1. Feb 19, 2026
    Currently in shortage
    4 of 4 products affected.
  2. Feb 19, 2026
    First reported to the FDA
    4 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

Which allopurinol products are affected — by company

Company: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Allopurinol Tablet, 300 mg NDC 00591-5544-01 300 mg — Discontinuation of the manufacture of the drug —
To Be Discontinued Allopurinol Tablet, 100 mg NDC 00591-5543-10 100 mg — Discontinuation of the manufacture of the drug —
To Be Discontinued Allopurinol Tablet, 100 mg NDC 00591-5543-01 100 mg — Discontinuation of the manufacture of the drug —
To Be Discontinued Allopurinol Tablet, 300 mg NDC 00591-5544-05 300 mg — Discontinuation of the manufacture of the drug —

These rows are company reports to the FDA for Allopurinol Tablet — they do not cover every company that lists this medicine. A company appears here only if it told the FDA it has a supply problem, so other companies may still have stock. That’s the basis for the Where else can I get allopurinol? options further down this page.

Why is Teva Pharmaceuticals discontinuing allopurinol?

A note from Dr. Brian Staiger, PharmD · Written Oct 7, 2026

Teva Pharmaceuticals has reported to the FDA that they are permanently stopping production of their allopurinol tablets — both the 100 mg and 300 mg strengths, across all of their package sizes. This isn't a temporary delay or a supply hiccup; Teva has decided to stop making these specific products for good.

It's worth knowing that Teva did not share a specific public reason why they made this decision — just that manufacturing is being discontinued. This report only covers Teva's versions of allopurinol, so it doesn't reflect what other manufacturers may be doing with their own products.

Based on the company-reported reason(s) and notes on file with the FDA for Allopurinol Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as companies report changes.

What should I do if I take allopurinol?

A note from Dr. Brian Staiger, PharmD · Written Oct 7, 2026

Allopurinol tablets are currently on the FDA shortage list. This report comes from one manufacturer, Teva Pharmaceuticals, which has decided to discontinue the medicine — so I want to walk you through what that means and what to do next.

Both strengths involved, the 100 mg and 300 mg tablets, are affected by Teva's decision. Teva is no longer making these, and the reason given is simply that they are stopping production. Because this is a discontinuation rather than a temporary supply problem, Teva's version may not return. The reassuring part is that several other companies still list both the 100 mg and 300 mg tablets, so the same medicine should remain available elsewhere.

Here is how to handle it:

  • Do not stop, skip, or change your allopurinol dose on your own.
  • Ask your pharmacy to order your strength from another maker — same-medicine options include Mylan, Par, Major, Rising, NorthStar, and Accord. Your pharmacy can check wholesalers, though a specific brand may not be in local stock right away.
  • If your pharmacy cannot find your exact tablet, ask your prescriber or pharmacist about the best next step.

Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls. This is national data and may not match your pharmacy's actual stock.

See “Where else can I get allopurinol?” below ↓ The same medicine from companies not reporting a shortage, other dosage forms, and therapeutic equivalents with pricing.
Quick checklist for the pharmacy counter:
  • Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
  • If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Keep reading
Our full Allopurinol guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Allopurinol guide →

Where else can I get allopurinol?

FDA shortages are company-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every company that lists allopurinol tablets is necessarily short. Below are the other listings in the current FDA NDC Directory that are not reported in shortage: the same medicine from companies that haven’t reported a problem (the reporting company is excluded), and other dosage forms. Some listings are repackagers, which relabel another company’s product. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine from other companies (not reporting a shortage)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from companies that have not filed a shortage with the FDA:

ProductStrengthForm / routeCompanyNDC
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Mylan Pharmaceuticals Inc. 00378-0137-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Mylan Pharmaceuticals Inc. 00378-0181-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Par Health USA, LLC 00603-2115-21
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Par Health USA, LLC 00603-2116-21
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Major Pharmaceuticals 00904-6572-61
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Major Pharmaceuticals 00904-7041-61
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Rising Pharma Holdings, Inc. 16571-0883-01
Allopurinol ALLOPURINOL 200 mg/1 Tablet · Oral Rising Pharma Holdings, Inc. 16571-0884-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Rising Pharma Holdings, Inc. 16571-0885-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral NorthStar RxLLC 16714-0576-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral NorthStar RxLLC 16714-0577-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Accord Healthcare Inc. 16729-0134-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Accord Healthcare Inc. 16729-0135-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0693-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0694-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Unichem Pharmaceuticals (USA), Inc. 29300-0349-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Unichem Pharmaceuticals (USA), Inc. 29300-0350-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Camber Pharmaceuticals, Inc. 31722-0252-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Camber Pharmaceuticals, Inc. 31722-0253-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral PD-Rx Pharmaceuticals, Inc. 43063-0934-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral PD-Rx Pharmaceuticals, Inc. 43063-0935-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Aphena Pharma Solutions - Tennessee, LLC 43353-0186-60
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Safecor Health, LLC 48433-0003-20
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral A-S Medication Solutions 50090-4662-03
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral A-S Medication Solutions 50090-4663-00
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Mylan Institutional Inc. 51079-0205-20
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Mylan Institutional Inc. 51079-0206-20
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Sun Pharmaceutical Industries, Inc. 53489-0156-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Sun Pharmaceutical Industries, Inc. 53489-0157-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Dr. Reddy's Laboratories Limited 55111-0729-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Dr. Reddy's Laboratories Limited 55111-0730-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Aurobindo Pharma Limited 59651-0285-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Aurobindo Pharma Limited 59651-0286-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral American Health Packaging 60687-0677-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral American Health Packaging 60687-0688-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral St. Mary's Medical Park Pharmacy 60760-0656-90
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral ST. MARY'S MEDICAL PARK PHARMACY 60760-0722-90
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Chartwell RX, LLC 62135-0516-31
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Chartwell RX, LLC 62135-0517-31
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Proficient Rx LP 63187-0240-30
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Proficient Rx LP 63187-0463-30
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Bryant Ranch Prepack 63629-1781-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Bryant Ranch Prepack 63629-2111-01
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral NuCare Pharmaceuticals, Inc. 66267-0665-30
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Aphena Pharma Solutions - Tennessee, LLC 67544-0736-60
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Leading Pharma, LLC 69315-0291-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Leading Pharma, LLC 69315-0292-01
Allopurinol ALLOPURINOL 200 mg/1 Tablet · Oral Leading Pharma, LLC 69315-0409-09
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral REMEDYREPACK INC. 70518-3660-00
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral REMEDYREPACK INC. 70518-3704-00
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Zydus Pharmaceuticals (USA) Inc. 70710-1209-00
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Zydus Pharmaceuticals (USA) Inc. 70710-1210-00
Allopurinol ALLOPURINOL 200 mg/1 Tablet · Oral Zydus Pharmaceuticals (USA) Inc. 70710-2009-00
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Florida Pharmaceutical Products, LLC 71921-0240-01
Allopurinol ALLOPURINOL 200 mg/1 Tablet · Oral Florida Pharmaceutical Products, LLC 71921-0241-09
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Florida Pharmaceutical Products, LLC 71921-0242-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral Direct_Rx 72189-0417-30
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral Direct_Rx 72189-0437-30
Allopurinol ALLOPURINOL 100 mg/1 Tablet · Oral XLCare Pharmaceuticals Inc. 72865-0303-01
Allopurinol ALLOPURINOL 300 mg/1 Tablet · Oral XLCare Pharmaceuticals Inc. 72865-0304-01
Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Allopurinol 100 mgNDC 00378-0137-01 Mylan 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 00591-5543-10 Actavis 1000 tablets $0.032 — Availability likely
Allopurinol 100 mgNDC 00603-2115-21 Par 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 00904-7041-61 Major 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 16571-0883-09 Rising 90 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 16714-0576-01 NorthStar 30 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 23155-0693-01 Heritage 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 29300-0349-01 Unichem 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 31722-0252-01 Camber 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 51079-0205-20 Mylan 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 53489-0156-01 Sun 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 55111-0729-01 Dr. 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 59651-0285-01 Aurobindo 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 60687-0677-01 American 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 62135-0516-31 Chartwell 300 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 69315-0291-01 Leading 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 70710-1209-00 Zydus 1000 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 71921-0240-01 Florida 100 tablets $0.032 AB Availability likely
Allopurinol 100 mgNDC 00591-5543-01 Actavis 100 tablets $0.032 — Discontinued
Allopurinol 100 mgNDC 16729-0134-01 Accord 100 tablets $0.033 +6% AB Availability likely
Allopurinol 300 mgNDC 00378-0181-01 Mylan 100 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 00591-5544-01 Actavis 100 tablets $0.052 — Availability likely
Allopurinol 300 mgNDC 00603-2116-21 Par 100 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 00904-6572-61 Major 100 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 16571-0885-09 Rising 90 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 16714-0577-01 NorthStar 100 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 23155-0694-01 Heritage 100 tablets $0.052 AB Discontinued
Allopurinol 300 mgNDC 29300-0350-01 Unichem 100 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 31722-0253-01 Camber 100 tablets $0.052 AB Availability likely
Allopurinol 300 mgNDC 51079-0206-20 Mylan 100 tablets $0.052 AB Availability likely

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of allopurinol — that fall in the same broad treatment class (hyperuricemia tx - xanthine oxidase inhibitors) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Febuxostat Allopurinol Sodium
Codes & classification for pharmacists and billers
GCN Seq No 002536
GCN 07071
HICL code 001100
Ingredient (HICL) Allopurinol
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C7
Therapeutic class — intermediate (HIC2) Metabolic Inhibitors And Stimulants
HIC3 code C7A
Therapeutic class — specific (HIC3) Hyperuricemia Tx - Xanthine Oxidase Inhibitors
AHFS code 92:16.00.00
AHFS class Antigout Agents
FDB label name ALLOPURINOL 300 MG TABLET
FDB brand name Allopurinol
Legend status F — Federal legend — prescription drug or device
GPI-1468000010000310
GPI classAllopurinol
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Allopurinol shortage FAQs

Is allopurinol still in shortage?
Not as a nationwide shortage — the FDA lists allopurinol tablets under “To be discontinued” as of Oct 6, 2026: Teva Pharmaceuticals has told the FDA it is stopping its own product, while 28 other companies still sell the same medicine and have not reported a problem.
Which strengths of allopurinol are affected?
The FDA record covers 2 strengths: 100 mg, 300 mg. Every strength on the record is still made by at least one company, though stock varies by pharmacy.
Which allopurinol products are affected?
Allopurinol Tablet, 300 mg (NDC 00591-5544-01); Allopurinol Tablet, 100 mg (NDC 00591-5543-10); Allopurinol Tablet, 100 mg (NDC 00591-5543-01) and 1 more. The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will allopurinol be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Mylan Pharmaceuticals, Par Health, Major Pharmaceuticals and 25 more, so ask your pharmacy to order another company’s version.
Can I still get allopurinol somewhere?
Other companies (Mylan Pharmaceuticals, Par Health, Major Pharmaceuticals and 25 more) sell the same medicine and have not reported a problem. See “Where else can I get allopurinol?” above — stock still varies by pharmacy.
What should I do if I take allopurinol?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the allopurinol shortage?

Ask a pharmacist about this shortage →

View Allopurinol Tablet on the FDA drug-shortage database →

How to read the Supply-Risk rating
Low (0–2)Several companies still list it and most strengths or pack sizes are still listed by someone — counting both the companies reporting the shortage and the companies listing the same medicine without a report. A listing is not a stock check.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes without a source, or a long-running outage. A company’s discontinuation notice is not an outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (companies listing the same ingredient & form — the "other companies" the rating counts); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages